Analystreport

Syros Pharmaceuticals Inc (NASDAQ: SYRS) had its price target raised by analysts at Piper Sandler from $12.00 to $14.00. They now have an "overweight" rating on the stock.

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com